Uh-Oh Labs

Uh-Oh Labs is a private, commercial-stage diagnostics company that has successfully launched its first product: the FDA-authorized UOL COVID-19 Test system. The company's proprietary Loop-de-Loop™ RT-LAMP platform forms the basis for a portable, rapid, and cost-effective molecular diagnostics system, which has garnered significant non-dilutive funding from the NIH's RADx initiative. With a core focus on infectious disease diagnostics, Uh-Oh Labs is leveraging its initial commercial foothold and strong financial backing to develop additional tests for its platform, targeting expansion beyond COVID-19.

Loop-de-Loop™ RT-LAMP: A patented, isothermal nucleic acid amplification chemistry enabling PCR-quality detection in a portable, low-cost instrument without complex thermal cycling.

Uh-Oh Labs competes in the rapid molecular diagnostics segment against companies like Cue Health (Cue MDx platform), Lucira Health (acquired by Pfizer), and Detect. It also faces competition from large diagnostics firms (e.g., Abbott ID NOW, Roche Liat) and numerous rapid antigen test providers. Its key differentiators are its claimed PCR-comparable accuracy, portability, and lower cost for a CLIA-waived NAAT.